Durvalumab Chemical Properties

storage temp. 

Store at 4°C, do not freeze

solubility 

Soluble in DMSO

form 

Liquid

color 

Colorless to light yellow

Durvalumab Usage And Synthesis

Uses

Durvalumab is used to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. Durvalumab injection is also used in combination with etoposide (Etopophos) and either carboplatin or cisplatin to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body.

Side effects

swelling of your arms or legs;constipation;hair loss

Durvalumab(1428935-60-7)Related Product Information

• Follicle stimulating hormone
• Secukinumab
• Daratumumab
• OMALIZUMAB
• Dulaglutide
• Trastuzumab emtansine
• Ranibizumab
• palivizumab
• Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
• Eculizumab
• Matuzumab
• ticilimumab tremelimumab
• CNTO 148
• Aflibercept
• abciximab
• Avelumab
• nimotuzumab
• belimumab